Bio2Brain

Bio2Brain - Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systems The Bio2Brain project is an EU-funded project that launched in January 2021. The aim of the Bio2Brain network is the development of a research and training program to train young scientists in innovating novel technologies to deliver biopharmaceuticals efficiently from the nose to the brain. It thereby offers a unique opportunity to 13 early career researchers to develop new paradigms and treatments in neurological diseases. Bio2Brain will create the fundament for the future transfer of the developed technologies for a later clinical development and GMP manufacturing. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956977.